These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 3404360

  • 41. Effects of pancreatic enzyme preparations on erythrocyte glutathione peroxidase activities and plasma selenium concentrations in cystic fibrosis.
    Winklhofer-Roob BM, Tiran B, Tuchschmid PE, van't Hof MA, Shmerling DH.
    Free Radic Biol Med; 1998 Jul 15; 25(2):242-9. PubMed ID: 9667502
    [Abstract] [Full Text] [Related]

  • 42. Efficacy and tolerability of a new formulation of pancrelipase delayed-release capsules in children aged 7 to 11 years with exocrine pancreatic insufficiency and cystic fibrosis: a multicenter, randomized, double-blind, placebo-controlled, two-period crossover, superiority study.
    Graff GR, Maguiness K, McNamara J, Morton R, Boyd D, Beckmann K, Bennett D.
    Clin Ther; 2010 Jan 15; 32(1):89-103. PubMed ID: 20171415
    [Abstract] [Full Text] [Related]

  • 43. Treatment failure after substitution of generic pancrelipase capsules. Correlation with in vitro lipase activity.
    Hendeles L, Dorf A, Stecenko A, Weinberger M.
    JAMA; 1990 May 09; 263(18):2459-61. PubMed ID: 2329633
    [Abstract] [Full Text] [Related]

  • 44. Nutrition and pancreatic enzyme intake in patients with cystic fibrosis with distal intestinal obstruction syndrome.
    Declercq D, Van Biervliet S, Robberecht E.
    Nutr Clin Pract; 2015 Feb 09; 30(1):134-7. PubMed ID: 25288253
    [Abstract] [Full Text] [Related]

  • 45. Desensitization to pancreatic enzyme intolerance in a child with cystic fibrosis.
    Chamarthy LM, Reinstein LJ, Schnapf B, Good RA, Bahna SL.
    Pediatrics; 1998 Jul 09; 102(1):e13. PubMed ID: 9651465
    [Abstract] [Full Text] [Related]

  • 46. Omeprazole, a proton pump inhibitor, improves residual steatorrhoea in cystic fibrosis patients treated with high dose pancreatic enzymes.
    Proesmans M, De Boeck K.
    Eur J Pediatr; 2003 Nov 09; 162(11):760-3. PubMed ID: 13680386
    [Abstract] [Full Text] [Related]

  • 47. 13Carbon mixed triglyceride breath test and pancreatic enzyme supplementation in cystic fibrosis.
    Amarri S, Harding M, Coward WA, Evans TJ, Weaver LT.
    Arch Dis Child; 1997 Apr 09; 76(4):349-51. PubMed ID: 9166030
    [Abstract] [Full Text] [Related]

  • 48. Omeprazole enhances the efficacy of pancreatin (pancrease) in cystic fibrosis.
    Heijerman HG, Lamers CB, Bakker W.
    Ann Intern Med; 1991 Feb 01; 114(3):200-1. PubMed ID: 1984743
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Pancreatic enzyme replacement therapy in cystic fibrosis: Australian guidelines. Pediatric Gastroenterological Society and the Dietitians Association of Australia.
    Anthony H, Collins CE, Davidson G, Mews C, Robinson P, Shepherd R, Stapleton D.
    J Paediatr Child Health; 1999 Apr 01; 35(2):125-9. PubMed ID: 10365346
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Mismatch of duodenal deliveries of dietary fat and pancreatin from enterically coated microspheres.
    Meyer JH, Lake R.
    Pancreas; 1997 Oct 01; 15(3):226-35. PubMed ID: 9336785
    [Abstract] [Full Text] [Related]

  • 54. Fibrosing colonopathy in cystic fibrosis: results of a case-control study.
    Smyth RL, Ashby D, O'Hea U, Burrows E, Lewis P, van Velzen D, Dodge JA.
    Lancet; 1995 Nov 11; 346(8985):1247-51. PubMed ID: 7475715
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. [Long-term treatment of mucoviscidosis. Results with a microencapsulated pancreatic enzyme preparation].
    Henker J, Hoffmann D, Paul D, Hein J, Paditz E.
    Fortschr Med; 1993 Feb 10; 111(4):53-6. PubMed ID: 8449468
    [Abstract] [Full Text] [Related]

  • 57. Solubility of oral pancreatic enzyme supplement capsules in biological fluids.
    Robb TS, Davidson GP, Cooper DM.
    Lancet; 1980 Sep 06; 2(8193):544. PubMed ID: 6105599
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.